Geographic Distribution of HCV Genotypes and Efficacy of Direct-Acting Antivirals in Chronic HCV-Infected Patients in North and Northeast China: A Real-World Multicenter Study
Table 2
Age-wise distribution of gender and HCV genotypes in HCV-infected patients.
Age
n (%)
Gender, n (%)
HCV genotypes, n (%)
Total
Male
1b
2a
3a/b
6a/n
Mixed
≤25
15 (1.02)
15
10 (66.67)
11 (72.33)
3 (20.00)
—
1 (6.67)
—
26–35
127 (8.62)
127
79 (62.20)
92 (72.33)
30 (23.62)
2 (1.57)
3 (2.36)
—
36–45
150 (10.18)
150
91 (60.67)
68 (45.34)
56 (37.33)
17 (11.33)
6 (4.00)
3 (2.00)
46–55
463 (31.41)
463
247 (53.35)
280 (60.48)
142 (30.67)
27 (5.83)
12 (2.59)
2 (0.43)
56–65
468 (31.75)
468
234 (50.00)
282 (60.26)
173 (36.97)
10 (2.14)
2(0.43)
1 (0.21)
66–75
212 (14.38)
212
105 (49.53)
129 (60.85)
80 (37.74)
2 (0.94)
1 (0.47)
—
>75
39 (2.65)
39
17 (43.59)
22 (56.41)
17 (43.59)
—
—
—
Total
1474
1474
783 (53.12)
884 (59.97)
501 (33.99)
58 (3.93)
25 (1.70)
6 (0.41)
Z
−3.249
−0.520
−3.400
-value
0.001
0.603
0.001
HCV: hepatitis C virus; mixed: mixed infections with two genotypes or subtypes.
